124 related articles for article (PubMed ID: 19578737)
1. Anti-tumor effects of fusion cells of type 1 dendritic cells and Meth A tumor cells using hemagglutinating virus of Japan-envelope.
Yanai S; Adachi Y; Fuijisawa J; Jiang S; Okigaki M; Shi M; Shima C; Imai Y; Kwon AH; Ikehara S
Int J Oncol; 2009 Aug; 35(2):249-55. PubMed ID: 19578737
[TBL] [Abstract][Full Text] [Related]
2. Intra-bone marrow injection of dendritic cells for treatment of malignant tumor in mice.
Koike-Kiriyama N; Koike Y; Adachi Y; Mukaide H; Minamino K; Shigematsu A; Kamiama Y; Matsumura M; Ikehara S
J Exp Clin Cancer Res; 2007 Sep; 26(3):337-42. PubMed ID: 17987792
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells.
Ogawa F; Iinuma H; Okinaga K
Scand J Immunol; 2004 May; 59(5):432-9. PubMed ID: 15140052
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for malignant tumors using combination of allogeneic intra-bone marrow-bone marrow transplantation, donor lymphocyte infusion and dendritic cells.
Mukaide H; Adachi Y; Koike-Kiriyama N; Suzuki Y; Minamino K; Iwasaki M; Tsuda M; Nakano K; Koike Y; Shigematsu A; Kamiyama Y; Ikehara S
Int J Oncol; 2007 Jun; 30(6):1309-15. PubMed ID: 17487350
[TBL] [Abstract][Full Text] [Related]
5. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells.
Kurooka M; Kaneda Y
Cancer Res; 2007 Jan; 67(1):227-36. PubMed ID: 17210703
[TBL] [Abstract][Full Text] [Related]
6. A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy.
Kawano H; Komaba S; Kanamori T; Kaneda Y
BMC Med; 2007 Sep; 5():28. PubMed ID: 17883878
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Th1 immune response by CD8alpha(+) dendritic cells loaded with heat shock proteins enriched tumor extract in tumor-bearing mice.
Azadmehr A; Pourfathollah AA; Amirghofran Z; Hassan ZM; Moazzeni SM
Cell Immunol; 2009; 260(1):28-32. PubMed ID: 19712929
[TBL] [Abstract][Full Text] [Related]
8. [Anti-tumor effects induced by fusion of interleukin-18 gene transfected NCI-H460 lung cancer cell line with dendritic cells].
Zhang ZY; Wu JM
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):17-20. PubMed ID: 17575687
[TBL] [Abstract][Full Text] [Related]
9. Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner.
Suzuki H; Kurooka M; Hiroaki Y; Fujiyoshi Y; Kaneda Y
FEBS Lett; 2008 Apr; 582(9):1325-9. PubMed ID: 18358837
[TBL] [Abstract][Full Text] [Related]
10. [Inducing specific antitumor effects on osteosarcoma by fused vaccine of rat dendritic cells].
Yu Z; Fan QY; Ma BA; Hao XB; Long H
Ai Zheng; 2005 Mar; 24(3):285-91. PubMed ID: 15757528
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma.
Takehara Y; Satoh T; Nishizawa A; Saeki K; Nakamura M; Masuzawa M; Kaneda Y; Katayama I; Yokozeki H
Clin Immunol; 2013 Oct; 149(1):1-10. PubMed ID: 23886549
[TBL] [Abstract][Full Text] [Related]
12. Development of HVJ envelope vector and its application to gene therapy.
Kaneda Y; Yamamoto S; Nakajima T
Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor activity on murine mastocytoma induced by immunization with fusion of dendritic cells and P815 cells in mice].
Wang QC; Feng ZH; Zhou YX; Nie QH; Bai XF
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):559-60. PubMed ID: 15387915
[No Abstract] [Full Text] [Related]
14. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
[TBL] [Abstract][Full Text] [Related]
15. The impact of Meth A fibrosarcoma derived EMAP II on dendritic cell migration.
Haridas S; Bowers M; Tusano J; Mehojah J; Kirkpatrick M; Burnham DK
Cytokine; 2008 Nov; 44(2):304-9. PubMed ID: 18951814
[TBL] [Abstract][Full Text] [Related]
16. The effect of vaccination with the lysate of heat-shocked tumor cells on nitric oxide production in BALB/c mice with fibrosarcoma tumor.
Hashemi SM; Hassan ZM; Soudi S; Shahabi S
Cell Biol Int; 2008 Jul; 32(7):835-40. PubMed ID: 18455932
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
18. Conditioning vaccination site with irradiated MIP-3alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine.
Shih NY; Yang HY; Cheng HT; Hung YM; Yao YC; Zhu YH; Wu YC; Liu KJ
J Immunother; 2009 May; 32(4):363-9. PubMed ID: 19342969
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitive effects of gastric cancer cell-dendritic cell fusion vaccine on tumor cell proliferation cycle].
Zhang K; Yu PW; Gao PF; Rao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):345-8. PubMed ID: 16886121
[TBL] [Abstract][Full Text] [Related]
20. Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence.
Ni J; Nolte B; Arnold A; Fournier P; Schirrmacher V
Vaccine; 2009 Sep; 27(40):5480-7. PubMed ID: 19616491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]